Skip to Main content Skip to Navigation
Journal articles

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumor necrosis factor alpha agents.

Abstract : Background and aims - Cerebrovascular accidents [CVA] have rarely been reported in inflammatory bowel disease [IBD] patients treated with anti-tumour necrosis alpha [anti-TNF alpha] agents. Our aim here was to describe the clinical course of CVA in these patients. Methods - This was a European Crohn's and Colitis Organisation [ECCO] retrospective observational study, performed as part of the CONFER [COllaborative Network For Exceptionally Rare case reports] project. A call to all ECCO members was made to report on IBD patients afflicted with CVA during treatment with anti-TNF alpha agents. Clinical data were recorded in a standardised case report form and analysed for event association with anti-TNF alpha treatment. Results - A total of 19 patients were identified from 16 centres: 14 had Crohn's disease, four ulcerative colitis and one IBD colitis unclassified [median age at diagnosis: 38.0 years, range: 18.6-62.5]. Patients received anti-TNF alpha for a median duration of 11.8 months [range: 0-62] at CVA onset; seven had previously been treated with at least one other anti-TNF alpha agent. Complete neurological recovery was observed in 16 patients. Anti-TNF alpha was discontinued in 16/19 patients. However, recurrent CVA or neurological deterioration was not observed in any of the 11 patients who received anti-TNF alpha after CVA [eight resumed after temporary cessation, three continued without interruption] for a median follow-up of 39.8 months [range: 5.6-98.2]. Conclusion - These preliminary findings do not unequivocally indicate a causal role of anti-TNF alpha in CVA complicating IBD. Resuming or continuing anti-TNF alpha in IBD patients with CVA may be feasible and safe in selected cases, but careful weighing of IBD activity versus neurological status is prudent.
Document type :
Journal articles
Complete list of metadata
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Monday, March 23, 2015 - 9:24:55 AM
Last modification on : Thursday, January 14, 2021 - 11:22:26 AM

Links full text



Konstantinos Karmiris, Peter Bossuyt, Dario Sorrentino, Tom Moreels, Antonella Scarcelli, et al.. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumor necrosis factor alpha agents.. Journal of Crohn's & Colitis, Oxford University Press 2015, 9 (5), pp.382-389. ⟨10.1093/ecco-jcc/jjv042⟩. ⟨hal-01134158⟩



Record views